Timothy Caulfield
Timothy Caulfield
Professor, Faculty of Law and School of Public Health, University of Alberta
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
Toward an understanding of transfusion‐related acute lung injury: statement of a consensus panel
S Kleinman, T Caulfield, P Chan, R Davenport, J McFarland, ...
Transfusion 44 (12), 1774-1789, 2004
8352004
Science communication reconsidered
T Bubela, MC Nisbet, R Borchelt, F Brunger, C Critchley, E Einsiedel, ...
Nature biotechnology 27 (6), 514-518, 2009
3622009
Do the print media “hype” genetic research? A comparison of newspaper stories and peer-reviewed research papers
TM Bubela, TA Caulfield
Cmaj 170 (9), 1399-1407, 2004
3432004
Stem cell clinics online: the direct-to-consumer portrayal of stem cell medicine
D Lau, U Ogbogu, B Taylor, T Stafinski, D Menon, T Caulfield
Cell stem cell 3 (6), 591-594, 2008
3322008
Research ethics recommendations for whole-genome research: consensus statement
T Caulfield, AL McGuire, M Cho, JA Buchanan, MM Burgess, U Danilczyk, ...
PLoS Biol 6 (3), e73, 2008
2652008
Research ethics and the challenge of whole-genome sequencing
AL McGuire, T Caulfield, MK Cho
Nature Reviews Genetics 9 (2), 152-156, 2008
2242008
Deflating the genomic bubble
JP Evans, EM Meslin, TM Marteau, T Caulfield
Science 331 (6019), 861-862, 2011
2112011
DNA databanks and consent: a suggested policy option involving an authorization model
T Caulfield, REG Upshur, A Daar
BMC medical ethics 4 (1), 1-4, 2003
1742003
Setting global standards for stem cell research and clinical translation: the 2016 ISSCR guidelines
GQ Daley, I Hyun, JF Apperley, RA Barker, N Benvenisty, AL Bredenoord, ...
Stem cell reports 6 (6), 787-797, 2016
1282016
Evidence and anecdotes: an analysis of human gene patenting controversies
T Caulfield, RM Cook-Deegan, FS Kieff, JP Walsh
Nature biotechnology 24 (9), 1091-1094, 2006
1282006
Biotechnology and the popular press: hype and the selling of science
T Caulfield
Trends in biotechnology 22 (7), 337-339, 2004
1202004
Point-counterpoint. Ethics and genomic incidental findings.
AL McGuire, S Joffe, BA Koenig, BB Biesecker, LB McCullough, ...
Science (New York, NY) 340 (6136), 1047-1048, 2013
1192013
Race and ancestry in biomedical research: exploring the challenges
T Caulfield, SM Fullerton, SE Ali-Khan, L Arbour, EG Burchard, ...
Genome medicine 1 (1), 1-8, 2009
1132009
Direct-to-consumer genetic testing: perceptions, problems, and policy responses
T Caulfield, AL McGuire
Annual review of medicine 63, 23-33, 2012
1072012
Biobanks and blanket consent: the proper place of the public good and public perception rationales
T Caulfield
King's Law Journal 18 (2), 209-226, 2007
1042007
Marketing of unproven stem cell–based interventions: A call to action
D Sipp, T Caulfield, J Kaye, J Barfoot, C Blackburn, S Chan, M De Luca, ...
Science translational medicine 9 (397), eaag0426, 2017
1022017
Science and the sources of hype
T Caulfield, C Condit
Public Health Genomics 15 (3-4), 209-217, 2012
1022012
Direct‐to‐consumer genetic testing: good, bad or benign?
T Caulfield, NM Ries, PN Ray, C Shuman, B Wilson
Clinical genetics 77 (2), 101-105, 2010
982010
Human dignity: a guide to policy making in the biotechnology era?
T Caulfield, R Brownsword
Nature Reviews Genetics 7 (1), 72-76, 2006
982006
Biobanks, consent and claims of consensus
Z Master, E Nelson, B Murdoch, T Caulfield
Nature Methods 9 (9), 885-888, 2012
912012
The system can't perform the operation now. Try again later.
Articles 1–20